Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.08 +0.06 (+2.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Profit After Tax (2025 - 2026)

Updated

Polaryx Therapeutics (PLYX) reported Profit After Tax of -$1.38 million for Q2 2026, compared with -$884,000 a year earlier.

Analysis

Polaryx Therapeutics (PLYX) Profit After Tax (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Polaryx Therapeutics' Profit After Tax came in at -$9.27 million; for FY2025, it was -$7.82 million.

  • By year, Profit After Tax came in at -$4.35 million in FY2024.
  • Five-year quarterly Profit After Tax spans a low of -$5.05 million in Q1 2025 and a high of -$884,000 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 5.28 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 3.09 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -246.00 Mn
10 Polaryx Therapeutics 103.68 Mn 79.29 Mn - -1.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.38 Mn
Mar 31, 2026 -1.96 Mn
Jun 30, 2025 -884,000.00
Mar 31, 2025 -5.05 Mn
API Access

Polaryx Therapeutics Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=PLYX&period=max&api_key=YOUR_API_KEY